List view / Grid view
18 April 2019 | By Nikki Withers (European Pharmaceutical Review)
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation...
12 April 2019 | By European Pharmaceutical Review
The report, published from CPhI Japan 2019, highlights the country as the second fastest growing mature market for solid dose drugs.
10 April 2019 | By European Pharmaceutical Review
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
8 April 2019 | By European Pharmaceutical Review
Some of the key findings show that job seekers are drawn to companies with long histories and large organisations with over 50,000 employees...
13 March 2019 | By Nikki Withers (European Pharmaceutical Review)
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies...
8 March 2019 | By Christof Hohne
The Merck v. Shionogi case of 2017 laid the groundwork for further establishing compulsory licensing as a strategic tool in Germany, particularly in pharma patent litigation. A recent decision in a proceeding brought by Sanofi now provides more guidance on the threshold for obtaining such a compulsory license. This article…
28 February 2019 | By European Pharmaceutical Review
The CMA provisionally finds Auden Mckenzie and Waymade broke the law by agreeing not to compete for the supply of hydrocortisone tablets to the NHS...
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Consumer demands, a focus on sustainability and recycling, and political uncertainty in the UK are just a few challenges the packaging market had to overcome last year. Nikki Withers speaks to Ron Yakubison, Director of Pharmaceutical Packaging Operations at Merck Manufacturing and Sriman Banerjee, Head of Packaging at GSK, who…
1 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin...
25 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Report shows consistent growth of the biopharmaceutical industry investment in neglected diseases...
15 January 2019 | By European Pharmaceutical Review
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices...
10 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
7 January 2019 | By European Pharmaceutical Review
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals...
7 December 2018 | By Pharmapack Europe
In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also accelerating across the drug delivery and packaging industries...
Follow: